发明名称 FGFR-FC FUSION PROTEINS AND THE USE THEREOF
摘要 The present invention belongs to the field of biotechnology and relates to the treatment of diseases, especially the treatment of FGF overexpression-related diseases. Particularly, the present invention relates to FGFR-Fc fusion proteins and the use thereof in the treatment of angiogenesis regulation-related diseases. More particularly, the present invention relates to isolated soluble FGFR-Fc fusion proteins and their applications in manufacture of the medicament for the treatment of angiogenesis regulation-related diseases.
申请公布号 WO2016191765(A1) 申请公布日期 2016.12.01
申请号 WO2016US35075 申请日期 2016.05.31
申请人 REMEGEN, LTD.;FANG, Jianmin;LI, Dong 发明人 FANG, Jianmin;LI, Dong
分类号 C07K16/28;A61K38/00;A61K47/48;C07K14/71 主分类号 C07K16/28
代理机构 代理人
主权项
地址